Evidence map›Paper›PMID 31004235›Full record

ArticlePharmaceutical research2019

Bottom-Up Fabrication of Multilayer Enteric Devices for the Oral Delivery of Peptides.

Cameron L Nemeth, William R Lykins, Huyen Tran, Mohamed E H ElSayed, Tejal A Desai

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. One-step preparation of CrNanoscale advances · 2021
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Micro and nanoscale technologies in oral drug delivery.Advanced drug delivery reviews · 2020
    Review
  10. Orally ingestible medical devices for gut engineering.Advanced drug delivery reviews · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cameron L NemethUC Berkeley-UCSF Graduate Program in Bioengineering, San Francisco, CA, USA.
William R LykinsUC Berkeley-UCSF Graduate Program in Bioengineering, San Francisco, CA, USA.
Huyen TranEli Lilly and Company Biotechnology Discovery Research, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA.
Mohamed E H ElSayedEli Lilly and Company Biotechnology Discovery Research, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. mohamed.elsayed@lilly.com.
Tejal A DesaiUC Berkeley-UCSF Graduate Program in Bioengineering, San Francisco, CA, USA. Tejal.desai@ucsf.edu.ORCID http://orcid.org/0000-0003-3409-9208

Funding

National Science Foundation 0821619National Science Foundation 0949176National Science Foundation 1106400National Science Foundation 1650113
6 · The paper itself

Abstract

purposeTo develop a planar, asymmetric, micro-scale oral drug delivery vehicle by i) fabricating microdevice bodies with enteric materials, ii) efficiently and stably loading sensitive drug molecules, and iii) capping microdevices for controlled drug release.

methodsPicoliter-volume inkjet printing was used to fabricate microdevices through additive manufacturing via drop-by-drop deposition of enteric polymer materials. Microdevice bodies with reservoirs are fabricated through deposition of an enteric polymer, Eudragit FS 30 D. A model API, insulin, was loaded into each microdevice and retained its stability during printing and release. Eudragit L 100 and/or S 100 were used to cap microdevices and control the kinetics of insulin release in simulated intestinal conditions.

resultsMicrodevice morphologies and size can be tuned on the fly based on printing parameters to span from the microscale to the mesoscale. Insulin retained its stability throughout device fabrication and during in vitro release in simulated intestinal conditions. Insulin release kinetics, from burst release to no release, can be tailored by controlling the blend of the Eudragit capping material.

conclusionThis approach represents a uniquely scalable and flexible strategy for microdevice fabrication that overcomes limitations in loading sensitive biologics and in the tuneability of device geometries that are inherent to traditional microfabrication strategies.

Indexed as

Administration, OralDelayed-Action PreparationsDrug Delivery SystemsDrug LiberationEquipment DesignExcipientsFluorocarbon PolymersInsulinsMicrospheresParticle SizePolyvinylsPrinting, Three-DimensionalSurface PropertiesDelayed-Action PreparationsExcipientsFluorocarbon PolymersInsulinspolyvinylidene fluoridePolyvinylsBottom-up fabrication processenteric polymersoral peptide deliveryplanar microdevices

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.